#Look up drugs registration#

#Look up drugs registration#

Therefore, eligible entities in New Mexico, Puerto Rico, and Kentucky may immediately enroll for the 340B Program during the Public Health Emergency Declaration by the Secretary, rather than having to wait for the normal quarterly registration period. We recognize that circumstances surrounding disaster relief efforts warrant flexibility for entities eligible for participation in the 340B Program. Guidance to 340B Providers in New Mexico, Puerto Rico, and Kentucky Public Health Emergency Declaration by the Secretary HRSA respectfully disagrees with the recent District Court opinion finding that two other manufacturers had not violated the statute, and continues to evaluate its options.

District Court opinions involving the 340B Program agree with HRSA that three pharmaceutical manufacturers have unlawfully restricted access to 340B discounted drugs by covered entities that dispense medications through contract pharmacy arrangements – the core finding of HRSA's May 17, 2021, Violation Letters. We are pleased that two of three recent U.S. Statement From the Health Resources and Services Administration Regarding Recent Court Rulings Involving the 340B Program ET) or Requests will be evaluated on a case-by-case basis. If you believe that your hospital may be eligible for this exception and have not yet been contacted by HRSA, please contact the 340B Prime Vendor at 1-88 (Monday – Friday, 9 a.m.

The hospital must have been a covered entity on Janu(i.e., the day before the first day of the COVID-19 PHE).

The hospital's termination must have been as a result of actions taken by or other impact on the hospital in response to, or as a result of, the COVID-19 Public Health Emergency (PHE).

The hospital must have been terminated from the 340B Program due to an inability to meet the statutorily-required disproportionate share adjustment (DSH percentage) during Medicare cost reporting periods beginning Octoand ending no later than December 31, 2022.

Section 121 of the law permits certain hospitals to be reinstated into the 340B Drug Pricing Program if they meet the following conditions:

The Consolidated Appropriations Act of 2022 was signed into law on March 15, 2022. Implementation of Section 121 of the Consolidated Appropriations Act of 2022 Performance Measurement & Quality Improvement.Training & Technical Assistance Overview.